Product Information

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.1292 per EA under NDC 64380044001. Its NADAC has been published 59 times since Oct 8, 2025.

FDA first approved this application on Jun 15, 2016. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET

hydrocodone bitartrate and acetaminophen
$0.1292per EA
DEA Schedule CII

Strength

325; 5 mg/1; mg/1

NDC

64380044001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202935

FDA Approved

6/15/2016

TE Code

AA

On Market Since

9/1/2025

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has been published 59 times since Oct 8, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1292 per EA
All-time high$0.1388 (Aug 12, 2026)
All-time low$0.1273 (Oct 8, 2025)
52-week high$0.1388
52-week low$0.1276
Median price$0.1298
Average price$0.1316
Largest weekly change+3.1% (Jun 17, 2026)
Weeks tracked59
Tracking sinceOct 8, 2025

Price History

1W

-2.1%

1M

-5.1%

3M

-6.7%

6M

-1.4%

1Y

-0.1%

3Y

N/A

5Y

N/A

All

+1.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hydrocodone bitartrate and acetaminophen market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, manufactured by Strides Pharma Inc., is $0.1292 per EA (NDC 64380044001), effective Nov 18, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has held within roughly two percent of its current level. It has been tracked across 59 weekly CMS publications since Oct 8, 2025.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

Since Oct 8, 2025, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has ranged from a low of $0.1273 (Oct 8, 2025) to a high of $0.1388 (Aug 12, 2026), with a median of $0.1298 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET (NDC 64380044001) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.